Cargando…
Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
De novo experimental drug discovery is an expensive and time-consuming task. It requires the identification of drug-target interactions (DTIs) towards targets of biological interest, either to inhibit or enhance a specific molecular function. Dedicated computational models for protein simulation and...
Autores principales: | Coelho, Edgar D., Arrais, Joel P., Oliveira, José Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125559/ https://www.ncbi.nlm.nih.gov/pubmed/27893735 http://dx.doi.org/10.1371/journal.pcbi.1005219 |
Ejemplares similares
-
Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015) -
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022) -
Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020) -
DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020) -
Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces
por: Zheng, Yi, et al.
Publicado: (2019)